Skip to content

Clinical trials

Observational Connective Tissue Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Phase: Observational Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20041
20052
20071
20081
20091
20101
20122
20134
20142
20151
20162
20174
20182
20193
20203
20214
20222
20231
20242
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting15
Unknown status11
Not yet recruiting4
Terminated3
Withdrawn1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)5
Central Hospital, Nancy, France2
National Heart, Lung, and Blood Institute (NHLBI)2
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2
National Jewish Health2
University of Bonn2
University of Colorado, Denver2
American Thrombosis and Hemostasis Network1
Assiut University1
Azienda Unita Sanitaria Locale di Piacenza1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases57
Lung Diseases, Interstitial13
Arthritis, Rheumatoid8
Idiopathic Pulmonary Fibrosis8
Scleroderma, Systemic7
Autoimmune Diseases6
Rare Diseases6
Arthritis5
Lupus Erythematosus, Systemic5
Myositis5

Trials

Showing 26 to 50 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.